Corium International, Inc.(NASDAQ : CORI)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.45%||166.93||0.7%||$1253.55m|
|LLY||Eli Lilly & Co.||0.18%||311.43||1.1%||$814.08m|
|BMY||Bristol-Myers Squibb Co.||-0.73%||70.77||1.0%||$778.85m|
|MRK||Merck & Co., Inc.||-0.81%||86.80||0.7%||$691.58m|
|ALNY||Alnylam Pharmaceuticals, Inc.||-0.95%||200.78||8.2%||$207.03m|
|GBT||Global Blood Therapeutics, Inc.||0.03%||67.99||5.4%||$199.71m|
|NVO||Novo Nordisk A/S||-0.40%||97.92||0.1%||$170.11m|
|HZNP||Horizon Therapeutics Plc||0.54%||62.97||5.4%||$156.21m|
|SRPT||Sarepta Therapeutics, Inc.||-2.42%||108.19||12.4%||$128.76m|
Corium International is a privately-owned company engaged in the research, development and manufacture of advanced transdermal drug delivery technologies and products. Using its proprietary delivery technologies and its development and manufacturing expertise, Corium has developed a number of active and passive transdermal products with enhanced therapeutic or safety profiles. This self-funded product pipeline spans several therapeutic areas and is in various stages of development. Corium also has several partner-funded products with small, medium and large pharmaceutical companies in various stages of development, ranging from manufacturing to research and development.